Patents Assigned to CereMedix, Inc.
  • Compositions and methods for counteracting effects of reactive oxygen species and free radicals
    Publication number: 20060019901
    Abstract: Peptide compounds and methods for upregulating expression of a gene encoding an antioxidative enzyme, such as superoxide dismutase or catalase, to counteract harmful oxidative effects of reactive oxygen species and other free radicals are described. The peptide compounds may be used to treat or prevent diseases and conditions characterized by undesirable elevation of reactive oxygen species and other free radicals, to upregulate AP-1 gene expression, and to treat pain. The peptide compounds may be used as components of pharmaceuticals and dietary supplements.
    Type: Application
    Filed: November 24, 2004
    Publication date: January 26, 2006
    Applicant: CereMedix, Inc.
    Inventor: Victor Shashoua
  • Compositions and methods for counteracting effects of reactive oxygen species and free radicals
    Patent number: 6890896
    Abstract: Peptide compounds and methods for upregulating expression of a gene encoding an antioxidative enzyme, such as superoxide dismutase or catalase, to counteract harmful oxidative effects of reactive oxygen species and other free radicals are described. The peptide compounds may be used to treat or prevent diseases and conditions characterized by undesirable elevation of reactive oxygen species and other free radicals, to upregulate AP-1 gene expression, and to treat pain. The peptide compounds may be used as components of pharmaceuticals and dietary supplements.
    Type: Grant
    Filed: November 17, 2000
    Date of Patent: May 10, 2005
    Assignee: CereMedix, Inc.
    Inventor: Victor E. Shashoua
  • Compositions and methods for counteracting effects of reactive oxygen species and free radicals
    Publication number: 20050090446
    Abstract: Peptide compounds and methods for upregulating expression of a gene encoding an antioxidative enzyme, such as superoxide dismutase or catalase, to counteract harmful oxidative effects of reactive oxygen species and other free radicals are described. The peptide compounds may be used to treat or prevent diseases and conditions characterized by undesirable elevation of reactive oxygen species and other free radicals, to upregulate AP-1 gene expression, and to treat pain. The peptide compounds may be used as components of pharmaceuticals and dietary supplements.
    Type: Application
    Filed: November 11, 2004
    Publication date: April 28, 2005
    Applicant: CereMedix, Inc.
    Inventor: Victor Shashoua